Ductal Carcinoma in Situ
📧 Sign up to get email alerts when something new happens for Ductal Carcinoma in Situ.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIS [NA]
A clinical trial evaluating delayed selective sentinel node biopsy for patients undergoing mastectomy for ductal carcinoma in situ is curren…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: The PROMISE Study: Duavee in Women With DCIS [Phase 2]
Phase 2 clinical trial update for the PROMISE Study evaluating Duavee (bazedoxifene/conjugated estrogens) in postmenopausal women with ducta…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Patient Outcomes from Second Film-readers and Test Threshold Relaxation in Breast Screening
A completed study from the University of Warwick reports on patient outcomes when using a second film-reader approach and relaxed screening …
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure [NA]
This clinical trial update notes the completion of a study evaluating deep inspiration breath hold and prone irradiation to reduce cardiac r…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast [Phase 2]
Phase 2 trial testing an active form of tamoxifen (4-hydroxytamoxifen) delivered through the breast skin to treat ductal carcinoma in situ (…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ [Phase 3]
Phase 3 trial comparing adjuvant tamoxifen with anastrozole in postmenopausal women with ductal carcinoma in situ; the study has completed a…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity
Completed clinical trial assessing the impact of the microbiome on radiotherapy toxicity in breast cancer (DCIS and invasive breast cancer) …
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer [Phase 2]
Phase 2 trial results for hypofractionated radiation therapy in Stage 0 to IIB breast cancer have been completed with results posted in 2024…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer [Phase 2]
Phase 2 pilot trial investigating oxytocin and microRNA identification in nipple aspirate fluid, serum, and tissue from women with breast ca…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation [Phase 2]
Phase 2 trial update on radiation fractionation schedules for once-a-day accelerated partial breast irradiation in breast cancer and DCIS.
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ [Phase 3]
A Phase 3 trial update on delayed sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer [Phase 3]
Phase 3 trial evaluating tamoxifen citrate, letrozole, anastrozole, or exemestane with or without chemotherapy in invasive breast cancer (Rx…
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer [Phase 3]
This is a Phase 3 clinical trial update evaluating tamoxifen citrate, letrozole, anastrozole, or exemestane with or without chemotherapy in …
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery [Phase 1]
Phase I trial evaluating Endoxifen Gel versus placebo in women undergoing breast surgery, including DCIS, LCIS, and various stages of breast…
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery. [Phase 4]
Phase 4 clinical trial evaluating ultrasound-guided multiple-injection costotransverse block for mastectomy and primary reconstructive surge…
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery [Phase 2]
Phase 2 trial update on accelerated partial breast radiation therapy with high-dose-rate brachytherapy for early-stage breast cancer after s…
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ [Phase 3]
A Phase 3 trial evaluating radiation therapy with or without optional tamoxifen for treating ductal carcinoma in situ in women has completed…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant [Phase 2]
Phase 2 pre-surgical pharmacokinetic study of intramuscular and intraductal fulvestrant in female breast cancer settings has been terminated…
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors [Phase 2]
Phase 2 trial evaluating docosahexaenoic acid (DHA) in breast cancer survivors has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer [Phase 2]
A Phase 2 clinical trial comparing hypofractionated radiation therapy to standard radiation therapy for ductal carcinoma in situ or early in…
-
CLINICAL_TRIALS trial_result · 2021-11-16Clinical Trial Update: Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer [Phase 2]
Phase 2 clinical trial investigating naltrexone for treatment-emergent fatigue in patients receiving radiation therapy for breast cancer; st…
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients [Phase 2]
Phase 2 trial evaluating genotype/phenotype-guided supplementation of tamoxifen with endoxifen in breast cancer and DCIS patients has comple…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml® [NA]
A Phase IV trial update for breast brachytherapy using Mammosite-Ml in breast cancer and ductal carcinoma in situ has completed with results…
-
CLINICAL_TRIALS trial_result · 2021-06-29Clinical Trial Update: Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) [Phase 1, Phase 2]
Clinical trial evaluating chloroquine for ductal carcinoma in situ (DCIS) completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women [Phase 2]
Phase 2 trial update on anastrozole for chemoprevention in postmenopausal women with ductal carcinoma in situ (DCIS); trial completed with r…